HEADER ISOMERASE/IMMUNOSUPPRESSANT 17-DEC-07 3BO7 TITLE CRYSTAL STRUCTURE OF TOXOPLASMA GONDII PEPTIDYL-PROLYL CIS-TRANS TITLE 2 ISOMERASE, 541.M00136 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE CYCLOPHILIN-TYPE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: PPIASE, ROTAMASE; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CYCLOSPORIN A; COMPND 8 CHAIN: E, F, G, H; COMPND 9 SYNONYM: CICLOSPORIN, CICLOSPORINE; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TOXOPLASMA GONDII; SOURCE 3 ORGANISM_TAXID: 5811; SOURCE 4 GENE: 541.M00136; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: DH5A; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: P15-MHL; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM; SOURCE 13 ORGANISM_TAXID: 29910 KEYWDS ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, CYCLOPHILIN-CYCLOSPORIN COMPLEX, KEYWDS 2 CYCLOSPORIN A, IMMUNOSUPPRESSANT, CYCLOPHILIN, STRUCTURAL GENOMICS, KEYWDS 3 STRUCTURAL GENOMICS CONSORTIUM, SGC EXPDTA X-RAY DIFFRACTION AUTHOR A.K.WERNIMONT,J.LEW,I.KOZIERADZKI,Y.H.LIN,X.SUN,C.KHUU,Y.ZHAO, AUTHOR 2 M.SCHAPIRA,C.H.ARROWSMITH,A.M.EDWARDS,J.WEIGELT,A.BOCHKAREV,R.HUI, AUTHOR 3 J.D.ARTZ,T.XIAO,STRUCTURAL GENOMICS CONSORTIUM (SGC) REVDAT 5 03-APR-24 3BO7 1 REMARK LINK REVDAT 4 27-JUL-11 3BO7 1 REMARK REVDAT 3 13-JUL-11 3BO7 1 VERSN REVDAT 2 24-FEB-09 3BO7 1 VERSN REVDAT 1 19-FEB-08 3BO7 0 JRNL AUTH A.K.WERNIMONT,J.LEW,I.KOZIERADZKI,Y.H.LIN,X.SUN,C.KHUU, JRNL AUTH 2 Y.ZHAO,M.SCHAPIRA,C.H.ARROWSMITH,A.M.EDWARDS,J.WEIGELT, JRNL AUTH 3 A.BOCHKAREV,R.HUI,J.D.ARTZ,T.XIAO JRNL TITL CRYSTAL STRUCTURE OF TOXOPLASMA GONDII PEPTIDYL-PROLYL JRNL TITL 2 CIS-TRANS ISOMERASE, 541.M00136. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.54 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 47813 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2422 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.41 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3333 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE SET COUNT : 185 REMARK 3 BIN FREE R VALUE : 0.3420 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5676 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 138 REMARK 3 SOLVENT ATOMS : 484 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.12000 REMARK 3 B22 (A**2) : -0.31000 REMARK 3 B33 (A**2) : 0.14000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.07000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.256 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.219 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.162 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.865 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5974 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8059 ; 1.200 ; 1.999 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 697 ; 5.712 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 278 ;35.596 ;23.525 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1002 ;15.687 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 46 ;19.088 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 859 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4498 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2716 ; 0.199 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3967 ; 0.311 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 517 ; 0.130 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 33 ; 0.141 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.082 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3705 ; 0.505 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5790 ; 0.879 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2493 ; 1.166 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2259 ; 1.929 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 3 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B C D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 160 A 166 1 REMARK 3 1 B 160 B 166 1 REMARK 3 1 C 160 C 166 1 REMARK 3 1 D 160 D 166 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 51 ; 0.020 ; 0.050 REMARK 3 TIGHT POSITIONAL 1 B (A): 51 ; 0.020 ; 0.050 REMARK 3 TIGHT POSITIONAL 1 C (A): 51 ; 0.020 ; 0.050 REMARK 3 TIGHT POSITIONAL 1 D (A): 51 ; 0.020 ; 0.050 REMARK 3 TIGHT THERMAL 1 A (A**2): 51 ; 0.040 ; 0.500 REMARK 3 TIGHT THERMAL 1 B (A**2): 51 ; 0.080 ; 0.500 REMARK 3 TIGHT THERMAL 1 C (A**2): 51 ; 0.080 ; 0.500 REMARK 3 TIGHT THERMAL 1 D (A**2): 51 ; 0.040 ; 0.500 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : A B C D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 60 A 67 1 REMARK 3 1 B 60 B 67 1 REMARK 3 1 C 60 C 67 1 REMARK 3 1 D 60 D 67 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 2 A (A): 49 ; 0.030 ; 0.050 REMARK 3 TIGHT POSITIONAL 2 B (A): 49 ; 0.020 ; 0.050 REMARK 3 TIGHT POSITIONAL 2 C (A): 49 ; 0.040 ; 0.050 REMARK 3 TIGHT POSITIONAL 2 D (A): 49 ; 0.040 ; 0.050 REMARK 3 TIGHT THERMAL 2 A (A**2): 49 ; 0.040 ; 0.500 REMARK 3 TIGHT THERMAL 2 B (A**2): 49 ; 0.050 ; 0.500 REMARK 3 TIGHT THERMAL 2 C (A**2): 49 ; 0.090 ; 0.500 REMARK 3 TIGHT THERMAL 2 D (A**2): 49 ; 0.080 ; 0.500 REMARK 3 REMARK 3 NCS GROUP NUMBER : 3 REMARK 3 CHAIN NAMES : A D B C REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 127 A 130 2 REMARK 3 1 D 127 D 130 2 REMARK 3 1 B 127 B 130 2 REMARK 3 1 C 127 C 130 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 3 A (A): 16 ; 0.020 ; 0.050 REMARK 3 TIGHT POSITIONAL 3 D (A): 16 ; 0.010 ; 0.050 REMARK 3 TIGHT POSITIONAL 3 B (A): 16 ; 0.020 ; 0.050 REMARK 3 TIGHT POSITIONAL 3 C (A): 16 ; 0.020 ; 0.050 REMARK 3 MEDIUM POSITIONAL 3 A (A): 19 ; 0.540 ; 0.500 REMARK 3 MEDIUM POSITIONAL 3 D (A): 19 ; 0.240 ; 0.500 REMARK 3 MEDIUM POSITIONAL 3 B (A): 19 ; 0.200 ; 0.500 REMARK 3 MEDIUM POSITIONAL 3 C (A): 19 ; 0.220 ; 0.500 REMARK 3 TIGHT THERMAL 3 A (A**2): 16 ; 0.110 ; 0.500 REMARK 3 TIGHT THERMAL 3 D (A**2): 16 ; 0.050 ; 0.500 REMARK 3 TIGHT THERMAL 3 B (A**2): 16 ; 0.130 ; 0.500 REMARK 3 TIGHT THERMAL 3 C (A**2): 16 ; 0.090 ; 0.500 REMARK 3 MEDIUM THERMAL 3 A (A**2): 19 ; 0.680 ; 2.000 REMARK 3 MEDIUM THERMAL 3 D (A**2): 19 ; 0.450 ; 2.000 REMARK 3 MEDIUM THERMAL 3 B (A**2): 19 ; 0.510 ; 2.000 REMARK 3 MEDIUM THERMAL 3 C (A**2): 19 ; 0.580 ; 2.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3BO7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-DEC-07. REMARK 100 THE DEPOSITION ID IS D_1000045759. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-OCT-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54466 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.12400 REMARK 200 R SYM (I) : 0.08300 REMARK 200 FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.00000 REMARK 200 R SYM FOR SHELL (I) : 0.83400 REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2FUO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28% PEG 3350, 0.2 M LISO4, 0.1 M HEPES REMARK 280 PH 7.3, 2 MM TCEP, 2 MM CYCLOSPORIN A, 20% ETHYLENE GLYCOL, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 74.81550 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 50.40250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 74.81550 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 50.40250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -56.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -76.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -72.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: E, F, G, H REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION REMARK 400 IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 LYS A 2 REMARK 465 LEU A 3 REMARK 465 LYS A 4 REMARK 465 SER A 68 REMARK 465 LYS A 69 REMARK 465 LYS A 70 REMARK 465 LYS A 71 REMARK 465 GLU A 72 REMARK 465 VAL A 73 REMARK 465 GLN A 74 REMARK 465 GLU A 177 REMARK 465 ASP A 178 REMARK 465 ALA A 179 REMARK 465 ARG A 180 REMARK 465 LYS A 181 REMARK 465 GLU A 182 REMARK 465 MET A 183 REMARK 465 GLU A 184 REMARK 465 ASP A 185 REMARK 465 GLU A 186 REMARK 465 LYS A 187 REMARK 465 ARG A 188 REMARK 465 GLU A 189 REMARK 465 GLU A 190 REMARK 465 GLU A 191 REMARK 465 GLU A 192 REMARK 465 LYS A 193 REMARK 465 GLU A 194 REMARK 465 LYS A 195 REMARK 465 LYS A 196 REMARK 465 LYS A 197 REMARK 465 LEU A 198 REMARK 465 GLU A 199 REMARK 465 ASN A 200 REMARK 465 ALA A 201 REMARK 465 GLY B 1 REMARK 465 LYS B 2 REMARK 465 LEU B 3 REMARK 465 LYS B 4 REMARK 465 SER B 68 REMARK 465 LYS B 69 REMARK 465 LYS B 70 REMARK 465 LYS B 71 REMARK 465 GLU B 72 REMARK 465 VAL B 73 REMARK 465 ASP B 178 REMARK 465 ALA B 179 REMARK 465 ARG B 180 REMARK 465 LYS B 181 REMARK 465 GLU B 182 REMARK 465 MET B 183 REMARK 465 GLU B 184 REMARK 465 ASP B 185 REMARK 465 GLU B 186 REMARK 465 LYS B 187 REMARK 465 ARG B 188 REMARK 465 GLU B 189 REMARK 465 GLU B 190 REMARK 465 GLU B 191 REMARK 465 GLU B 192 REMARK 465 LYS B 193 REMARK 465 GLU B 194 REMARK 465 LYS B 195 REMARK 465 LYS B 196 REMARK 465 LYS B 197 REMARK 465 LEU B 198 REMARK 465 GLU B 199 REMARK 465 ASN B 200 REMARK 465 ALA B 201 REMARK 465 GLY C 1 REMARK 465 LYS C 2 REMARK 465 LEU C 3 REMARK 465 LYS C 4 REMARK 465 LYS C 71 REMARK 465 GLU C 72 REMARK 465 VAL C 73 REMARK 465 GLN C 74 REMARK 465 ASP C 178 REMARK 465 ALA C 179 REMARK 465 ARG C 180 REMARK 465 LYS C 181 REMARK 465 GLU C 182 REMARK 465 MET C 183 REMARK 465 GLU C 184 REMARK 465 ASP C 185 REMARK 465 GLU C 186 REMARK 465 LYS C 187 REMARK 465 ARG C 188 REMARK 465 GLU C 189 REMARK 465 GLU C 190 REMARK 465 GLU C 191 REMARK 465 GLU C 192 REMARK 465 LYS C 193 REMARK 465 GLU C 194 REMARK 465 LYS C 195 REMARK 465 LYS C 196 REMARK 465 LYS C 197 REMARK 465 LEU C 198 REMARK 465 GLU C 199 REMARK 465 ASN C 200 REMARK 465 ALA C 201 REMARK 465 GLY D 1 REMARK 465 LYS D 2 REMARK 465 LEU D 3 REMARK 465 SER D 68 REMARK 465 LYS D 69 REMARK 465 LYS D 70 REMARK 465 LYS D 71 REMARK 465 GLU D 72 REMARK 465 VAL D 73 REMARK 465 ASP D 178 REMARK 465 ALA D 179 REMARK 465 ARG D 180 REMARK 465 LYS D 181 REMARK 465 GLU D 182 REMARK 465 MET D 183 REMARK 465 GLU D 184 REMARK 465 ASP D 185 REMARK 465 GLU D 186 REMARK 465 LYS D 187 REMARK 465 ARG D 188 REMARK 465 GLU D 189 REMARK 465 GLU D 190 REMARK 465 GLU D 191 REMARK 465 GLU D 192 REMARK 465 LYS D 193 REMARK 465 GLU D 194 REMARK 465 LYS D 195 REMARK 465 LYS D 196 REMARK 465 LYS D 197 REMARK 465 LEU D 198 REMARK 465 GLU D 199 REMARK 465 ASN D 200 REMARK 465 ALA D 201 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PRO A 67 CG CD REMARK 470 LYS A 156 CG CD CE NZ REMARK 470 LYS A 162 CD CE NZ REMARK 470 ARG B 78 NE CZ NH1 NH2 REMARK 470 LYS C 70 CG CD CE NZ REMARK 470 LYS C 156 CG CD CE NZ REMARK 470 LYS C 157 CE NZ REMARK 470 LYS C 162 CD CE NZ REMARK 470 LYS D 4 CG CD CE NZ REMARK 470 GLU D 153 CG CD OE1 OE2 REMARK 470 LYS D 156 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASP D 144 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 45 -5.16 80.06 REMARK 500 PHE A 55 -83.49 -137.47 REMARK 500 LEU A 116 -87.95 -124.68 REMARK 500 CYS A 126 61.52 -155.20 REMARK 500 ASP A 155 -160.74 -74.68 REMARK 500 LYS A 173 119.47 -163.07 REMARK 500 PHE B 55 -89.19 -137.05 REMARK 500 LEU B 116 -90.29 -118.04 REMARK 500 CYS B 126 59.22 -147.70 REMARK 500 ASP B 158 19.59 58.96 REMARK 500 ASP C 45 -3.51 72.26 REMARK 500 PHE C 55 -91.60 -131.37 REMARK 500 GLN C 66 72.58 -106.72 REMARK 500 LEU C 116 -91.36 -118.69 REMARK 500 CYS C 126 56.34 -143.54 REMARK 500 ASP C 155 -169.76 -71.55 REMARK 500 ASP D 45 -2.88 78.17 REMARK 500 PHE D 55 -92.70 -132.49 REMARK 500 LEU D 116 -87.62 -122.52 REMARK 500 CYS D 126 58.27 -151.35 REMARK 500 ABA G 6 70.60 -114.06 REMARK 500 MLE G 10 -163.28 -101.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 206 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 204 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 205 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 204 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 205 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 206 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 207 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 208 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO C 209 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 204 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 205 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 206 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 207 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO D 208 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO D 209 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO D 210 REMARK 800 REMARK 800 SITE_IDENTIFIER: DC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO D 211 REMARK 800 REMARK 800 SITE_IDENTIFIER: DC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO G 12 REMARK 800 REMARK 800 SITE_IDENTIFIER: DC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: DC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: DC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN G OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: DC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN H OF CYCLOSPORIN A REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 C REMARK 900 RELATED ID: 1C5F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CSA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1CWA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 1CWB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 1CWC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 D REMARK 900 RELATED ID: 1CWH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A MODIFIED AT POSITION 7 REMARK 900 RELATED ID: 1CWI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITION 7 REMARK 900 RELATED ID: 1CWJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH NODIFIED REMARK 900 CYCLOSPORIN C AT POSITIONS 1, AND 9 REMARK 900 RELATED ID: 1CYA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WIYH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYB RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1IKF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CTCLOSPORIN-FAB COMPLEX REMARK 900 RELATED ID: 1M63 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN COMPLEX REMARK 900 RELATED ID: 1MF8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN REMARK 900 CYCLOPHILIN AND CYCLOSPORIN A REMARK 900 RELATED ID: 1MIK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 6 REMARK 900 RELATED ID: 1QNG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED REMARK 900 WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1QNH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE REMARK 900 MUTANT) COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1XQ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2ESL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2OJU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2POY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II CYCLOPHILIN A REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2RMA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2RMB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 2RMC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2WFJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN G REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2X2C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2X7K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2Z6W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3CYS RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3EOV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI COMPLEXED REMARK 900 WITH CYCLOSPORIN A DBREF 3BO7 A 1 201 UNP D0VWS5 D0VWS5_TOXGO 1 201 DBREF 3BO7 B 1 201 UNP D0VWS5 D0VWS5_TOXGO 1 201 DBREF 3BO7 C 1 201 UNP D0VWS5 D0VWS5_TOXGO 1 201 DBREF 3BO7 D 1 201 UNP D0VWS5 D0VWS5_TOXGO 1 201 DBREF 3BO7 E 1 11 NOR NOR00033 NOR00033 1 11 DBREF 3BO7 F 1 11 NOR NOR00033 NOR00033 1 11 DBREF 3BO7 G 1 11 NOR NOR00033 NOR00033 1 11 DBREF 3BO7 H 1 11 NOR NOR00033 NOR00033 1 11 SEQRES 1 A 201 GLY LYS LEU LYS LYS LYS GLY TYR LEU ARG ILE VAL THR SEQRES 2 A 201 THR GLN GLY SER LEU ASN ILE GLU LEU HIS ALA ASP MET SEQRES 3 A 201 ALA PRO ARG ALA CYS ASP SER PHE LEU ARG LEU CYS ALA SEQRES 4 A 201 VAL LYS TYR PHE ASP ASP THR ILE PHE HIS ARG CYS ILE SEQRES 5 A 201 ARG ASN PHE MET ILE GLN GLY GLY ARG ALA GLU LEU ARG SEQRES 6 A 201 GLN PRO SER LYS LYS LYS GLU VAL GLN GLN SER PRO ARG SEQRES 7 A 201 SER ILE SER GLY PHE PRO GLY GLY ALA PRO PHE GLU ASP SEQRES 8 A 201 GLU PHE ASP ASN ARG LEU VAL HIS GLN GLY ILE GLY VAL SEQRES 9 A 201 LEU SER MET ALA ASN ASP GLY LYS HIS SER ASN LEU SER SEQRES 10 A 201 GLU PHE PHE ILE THR PHE LYS SER CYS GLU HIS LEU ASN SEQRES 11 A 201 ASN LYS HIS THR ILE PHE GLY ARG VAL VAL GLY GLY LEU SEQRES 12 A 201 ASP VAL LEU ARG GLN TRP GLU LYS LEU GLU THR ASP LYS SEQRES 13 A 201 LYS ASP LYS PRO LEU LYS PRO PRO LYS VAL GLU GLU ILE SEQRES 14 A 201 ILE VAL PHE LYS ASN PRO PHE GLU ASP ALA ARG LYS GLU SEQRES 15 A 201 MET GLU ASP GLU LYS ARG GLU GLU GLU GLU LYS GLU LYS SEQRES 16 A 201 LYS LYS LEU GLU ASN ALA SEQRES 1 B 201 GLY LYS LEU LYS LYS LYS GLY TYR LEU ARG ILE VAL THR SEQRES 2 B 201 THR GLN GLY SER LEU ASN ILE GLU LEU HIS ALA ASP MET SEQRES 3 B 201 ALA PRO ARG ALA CYS ASP SER PHE LEU ARG LEU CYS ALA SEQRES 4 B 201 VAL LYS TYR PHE ASP ASP THR ILE PHE HIS ARG CYS ILE SEQRES 5 B 201 ARG ASN PHE MET ILE GLN GLY GLY ARG ALA GLU LEU ARG SEQRES 6 B 201 GLN PRO SER LYS LYS LYS GLU VAL GLN GLN SER PRO ARG SEQRES 7 B 201 SER ILE SER GLY PHE PRO GLY GLY ALA PRO PHE GLU ASP SEQRES 8 B 201 GLU PHE ASP ASN ARG LEU VAL HIS GLN GLY ILE GLY VAL SEQRES 9 B 201 LEU SER MET ALA ASN ASP GLY LYS HIS SER ASN LEU SER SEQRES 10 B 201 GLU PHE PHE ILE THR PHE LYS SER CYS GLU HIS LEU ASN SEQRES 11 B 201 ASN LYS HIS THR ILE PHE GLY ARG VAL VAL GLY GLY LEU SEQRES 12 B 201 ASP VAL LEU ARG GLN TRP GLU LYS LEU GLU THR ASP LYS SEQRES 13 B 201 LYS ASP LYS PRO LEU LYS PRO PRO LYS VAL GLU GLU ILE SEQRES 14 B 201 ILE VAL PHE LYS ASN PRO PHE GLU ASP ALA ARG LYS GLU SEQRES 15 B 201 MET GLU ASP GLU LYS ARG GLU GLU GLU GLU LYS GLU LYS SEQRES 16 B 201 LYS LYS LEU GLU ASN ALA SEQRES 1 C 201 GLY LYS LEU LYS LYS LYS GLY TYR LEU ARG ILE VAL THR SEQRES 2 C 201 THR GLN GLY SER LEU ASN ILE GLU LEU HIS ALA ASP MET SEQRES 3 C 201 ALA PRO ARG ALA CYS ASP SER PHE LEU ARG LEU CYS ALA SEQRES 4 C 201 VAL LYS TYR PHE ASP ASP THR ILE PHE HIS ARG CYS ILE SEQRES 5 C 201 ARG ASN PHE MET ILE GLN GLY GLY ARG ALA GLU LEU ARG SEQRES 6 C 201 GLN PRO SER LYS LYS LYS GLU VAL GLN GLN SER PRO ARG SEQRES 7 C 201 SER ILE SER GLY PHE PRO GLY GLY ALA PRO PHE GLU ASP SEQRES 8 C 201 GLU PHE ASP ASN ARG LEU VAL HIS GLN GLY ILE GLY VAL SEQRES 9 C 201 LEU SER MET ALA ASN ASP GLY LYS HIS SER ASN LEU SER SEQRES 10 C 201 GLU PHE PHE ILE THR PHE LYS SER CYS GLU HIS LEU ASN SEQRES 11 C 201 ASN LYS HIS THR ILE PHE GLY ARG VAL VAL GLY GLY LEU SEQRES 12 C 201 ASP VAL LEU ARG GLN TRP GLU LYS LEU GLU THR ASP LYS SEQRES 13 C 201 LYS ASP LYS PRO LEU LYS PRO PRO LYS VAL GLU GLU ILE SEQRES 14 C 201 ILE VAL PHE LYS ASN PRO PHE GLU ASP ALA ARG LYS GLU SEQRES 15 C 201 MET GLU ASP GLU LYS ARG GLU GLU GLU GLU LYS GLU LYS SEQRES 16 C 201 LYS LYS LEU GLU ASN ALA SEQRES 1 D 201 GLY LYS LEU LYS LYS LYS GLY TYR LEU ARG ILE VAL THR SEQRES 2 D 201 THR GLN GLY SER LEU ASN ILE GLU LEU HIS ALA ASP MET SEQRES 3 D 201 ALA PRO ARG ALA CYS ASP SER PHE LEU ARG LEU CYS ALA SEQRES 4 D 201 VAL LYS TYR PHE ASP ASP THR ILE PHE HIS ARG CYS ILE SEQRES 5 D 201 ARG ASN PHE MET ILE GLN GLY GLY ARG ALA GLU LEU ARG SEQRES 6 D 201 GLN PRO SER LYS LYS LYS GLU VAL GLN GLN SER PRO ARG SEQRES 7 D 201 SER ILE SER GLY PHE PRO GLY GLY ALA PRO PHE GLU ASP SEQRES 8 D 201 GLU PHE ASP ASN ARG LEU VAL HIS GLN GLY ILE GLY VAL SEQRES 9 D 201 LEU SER MET ALA ASN ASP GLY LYS HIS SER ASN LEU SER SEQRES 10 D 201 GLU PHE PHE ILE THR PHE LYS SER CYS GLU HIS LEU ASN SEQRES 11 D 201 ASN LYS HIS THR ILE PHE GLY ARG VAL VAL GLY GLY LEU SEQRES 12 D 201 ASP VAL LEU ARG GLN TRP GLU LYS LEU GLU THR ASP LYS SEQRES 13 D 201 LYS ASP LYS PRO LEU LYS PRO PRO LYS VAL GLU GLU ILE SEQRES 14 D 201 ILE VAL PHE LYS ASN PRO PHE GLU ASP ALA ARG LYS GLU SEQRES 15 D 201 MET GLU ASP GLU LYS ARG GLU GLU GLU GLU LYS GLU LYS SEQRES 16 D 201 LYS LYS LEU GLU ASN ALA SEQRES 1 E 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 F 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 G 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 H 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA HET DAL E 1 5 HET MLE E 2 9 HET MLE E 3 9 HET MVA E 4 8 HET BMT E 5 13 HET ABA E 6 6 HET SAR E 7 5 HET MLE E 8 9 HET MLE E 10 9 HET DAL F 1 5 HET MLE F 2 9 HET MLE F 3 9 HET MVA F 4 8 HET BMT F 5 13 HET ABA F 6 6 HET SAR F 7 5 HET MLE F 8 9 HET MLE F 10 9 HET DAL G 1 5 HET MLE G 2 9 HET MLE G 3 9 HET MVA G 4 8 HET BMT G 5 13 HET ABA G 6 6 HET SAR G 7 5 HET MLE G 8 9 HET MLE G 10 9 HET DAL H 1 5 HET MLE H 2 9 HET MLE H 3 9 HET MVA H 4 8 HET BMT H 5 13 HET ABA H 6 6 HET SAR H 7 5 HET MLE H 8 9 HET MLE H 10 9 HET SO4 A 202 5 HET SO4 A 203 5 HET SO4 A 204 5 HET SO4 A 205 5 HET SO4 A 206 5 HET EDO A 207 4 HET SO4 B 202 5 HET SO4 B 203 5 HET SO4 B 204 5 HET SO4 B 205 5 HET SO4 C 202 5 HET SO4 C 203 5 HET SO4 C 204 5 HET SO4 C 205 5 HET SO4 C 206 5 HET SO4 C 207 5 HET SO4 C 208 5 HET EDO C 209 4 HET SO4 D 202 5 HET SO4 D 203 5 HET SO4 D 204 5 HET SO4 D 205 5 HET SO4 D 206 5 HET SO4 D 207 5 HET EDO D 208 4 HET EDO D 209 4 HET EDO D 210 4 HET EDO D 211 4 HET EDO G 12 4 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 5 DAL 4(C3 H7 N O2) FORMUL 5 MLE 16(C7 H15 N O2) FORMUL 5 MVA 4(C6 H13 N O2) FORMUL 5 BMT 4(C10 H19 N O3) FORMUL 5 ABA 4(C4 H9 N O2) FORMUL 5 SAR 4(C3 H7 N O2) FORMUL 9 SO4 22(O4 S 2-) FORMUL 14 EDO 7(C2 H6 O2) FORMUL 38 HOH *484(H2 O) HELIX 1 1 ALA A 27 VAL A 40 1 14 HELIX 2 2 ARG A 61 ARG A 65 5 5 HELIX 3 3 CYS A 126 ASN A 130 5 5 HELIX 4 4 GLY A 142 GLU A 150 1 9 HELIX 5 5 ALA B 27 ALA B 39 1 13 HELIX 6 6 ARG B 61 ARG B 65 5 5 HELIX 7 7 CYS B 126 ASN B 130 5 5 HELIX 8 8 GLY B 142 GLU B 150 1 9 HELIX 9 9 ALA C 27 VAL C 40 1 14 HELIX 10 10 ARG C 61 ARG C 65 5 5 HELIX 11 11 CYS C 126 ASN C 130 5 5 HELIX 12 12 GLY C 142 LYS C 151 1 10 HELIX 13 13 ALA D 27 ALA D 39 1 13 HELIX 14 14 ARG D 61 ARG D 65 5 5 HELIX 15 15 CYS D 126 ASN D 130 5 5 HELIX 16 16 GLY D 142 LYS D 151 1 10 SHEET 1 AA 8 PHE A 48 ILE A 52 0 SHEET 2 AA 8 MET A 56 GLY A 59 -1 O MET A 56 N ILE A 52 SHEET 3 AA 8 PHE A 119 THR A 122 -1 O PHE A 119 N GLY A 59 SHEET 4 AA 8 VAL A 104 MET A 107 -1 O VAL A 104 N THR A 122 SHEET 5 AA 8 ILE A 135 GLY A 141 -1 N PHE A 136 O LEU A 105 SHEET 6 AA 8 GLY A 16 LEU A 22 -1 O ASN A 19 N VAL A 140 SHEET 7 AA 8 GLY A 7 THR A 13 -1 O GLY A 7 N LEU A 22 SHEET 8 AA 8 VAL A 166 LYS A 173 -1 N GLU A 167 O VAL A 12 SHEET 1 BA 8 PHE B 48 ILE B 52 0 SHEET 2 BA 8 MET B 56 GLY B 59 -1 O MET B 56 N ILE B 52 SHEET 3 BA 8 PHE B 119 THR B 122 -1 O PHE B 119 N GLY B 59 SHEET 4 BA 8 VAL B 104 MET B 107 -1 O VAL B 104 N THR B 122 SHEET 5 BA 8 ILE B 135 GLY B 141 -1 N PHE B 136 O LEU B 105 SHEET 6 BA 8 GLY B 16 LEU B 22 -1 O ASN B 19 N VAL B 140 SHEET 7 BA 8 GLY B 7 THR B 13 -1 O GLY B 7 N LEU B 22 SHEET 8 BA 8 VAL B 166 LYS B 173 -1 N GLU B 167 O VAL B 12 SHEET 1 CA 8 PHE C 48 CYS C 51 0 SHEET 2 CA 8 MET C 56 GLY C 59 -1 O GLN C 58 N ARG C 50 SHEET 3 CA 8 PHE C 119 THR C 122 -1 O PHE C 119 N GLY C 59 SHEET 4 CA 8 VAL C 104 MET C 107 -1 O VAL C 104 N THR C 122 SHEET 5 CA 8 ILE C 135 GLY C 141 -1 N PHE C 136 O LEU C 105 SHEET 6 CA 8 GLY C 16 LEU C 22 -1 O ASN C 19 N VAL C 140 SHEET 7 CA 8 GLY C 7 THR C 13 -1 O GLY C 7 N LEU C 22 SHEET 8 CA 8 VAL C 166 LYS C 173 -1 N GLU C 167 O VAL C 12 SHEET 1 DA 8 PHE D 48 ILE D 52 0 SHEET 2 DA 8 MET D 56 GLY D 59 -1 O MET D 56 N ILE D 52 SHEET 3 DA 8 PHE D 119 THR D 122 -1 O PHE D 119 N GLY D 59 SHEET 4 DA 8 VAL D 104 MET D 107 -1 O VAL D 104 N THR D 122 SHEET 5 DA 8 ILE D 135 GLY D 141 -1 N PHE D 136 O LEU D 105 SHEET 6 DA 8 GLY D 16 LEU D 22 -1 O ASN D 19 N VAL D 140 SHEET 7 DA 8 GLY D 7 THR D 13 -1 O GLY D 7 N LEU D 22 SHEET 8 DA 8 VAL D 166 LYS D 173 -1 N GLU D 167 O VAL D 12 LINK C DAL E 1 N MLE E 2 1555 1555 1.34 LINK N DAL E 1 C ALA E 11 1555 1555 1.34 LINK C MLE E 2 N MLE E 3 1555 1555 1.34 LINK C MLE E 3 N MVA E 4 1555 1555 1.34 LINK C BMT E 5 N ABA E 6 1555 1555 1.33 LINK C ABA E 6 N SAR E 7 1555 1555 1.34 LINK C SAR E 7 N MLE E 8 1555 1555 1.33 LINK C MLE E 8 N VAL E 9 1555 1555 1.33 LINK C VAL E 9 N MLE E 10 1555 1555 1.33 LINK C MLE E 10 N ALA E 11 1555 1555 1.33 LINK C DAL F 1 N MLE F 2 1555 1555 1.34 LINK N DAL F 1 C ALA F 11 1555 1555 1.33 LINK C MLE F 2 N MLE F 3 1555 1555 1.33 LINK C MLE F 3 N MVA F 4 1555 1555 1.34 LINK C BMT F 5 N ABA F 6 1555 1555 1.34 LINK C ABA F 6 N SAR F 7 1555 1555 1.34 LINK C SAR F 7 N MLE F 8 1555 1555 1.33 LINK C MLE F 8 N VAL F 9 1555 1555 1.33 LINK C VAL F 9 N MLE F 10 1555 1555 1.34 LINK C MLE F 10 N ALA F 11 1555 1555 1.34 LINK C DAL G 1 N MLE G 2 1555 1555 1.34 LINK N DAL G 1 C ALA G 11 1555 1555 1.33 LINK C MLE G 2 N MLE G 3 1555 1555 1.34 LINK C MLE G 3 N MVA G 4 1555 1555 1.34 LINK C BMT G 5 N ABA G 6 1555 1555 1.33 LINK C ABA G 6 N SAR G 7 1555 1555 1.34 LINK C SAR G 7 N MLE G 8 1555 1555 1.34 LINK C MLE G 8 N VAL G 9 1555 1555 1.33 LINK C VAL G 9 N MLE G 10 1555 1555 1.34 LINK C MLE G 10 N ALA G 11 1555 1555 1.33 LINK C DAL H 1 N MLE H 2 1555 1555 1.34 LINK N DAL H 1 C ALA H 11 1555 1555 1.33 LINK C MLE H 2 N MLE H 3 1555 1555 1.34 LINK C MLE H 3 N MVA H 4 1555 1555 1.34 LINK C BMT H 5 N ABA H 6 1555 1555 1.33 LINK C ABA H 6 N SAR H 7 1555 1555 1.33 LINK C SAR H 7 N MLE H 8 1555 1555 1.34 LINK C MLE H 8 N VAL H 9 1555 1555 1.32 LINK C VAL H 9 N MLE H 10 1555 1555 1.34 LINK C MLE H 10 N ALA H 11 1555 1555 1.33 SITE 1 AC1 4 ARG A 29 PHE A 89 GLU A 90 HOH A2110 SITE 1 AC2 6 LYS A 112 SO4 A 204 HOH A2111 HIS C 113 SITE 2 AC2 6 HOH C2106 LYS D 112 SITE 1 AC3 5 LYS A 112 SO4 A 203 HOH A2112 HIS B 113 SITE 2 AC3 5 LYS D 112 SITE 1 AC4 6 ARG A 61 GLU A 63 LEU A 64 HOH A2113 SITE 2 AC4 6 HOH A2114 SO4 D 203 SITE 1 AC5 2 ASP A 155 LYS A 156 SITE 1 AC6 2 ARG A 29 ARG A 36 SITE 1 AC7 4 ARG B 29 PHE B 89 GLU B 90 HOH B2123 SITE 1 AC8 3 GLY B 101 LYS B 124 SER B 125 SITE 1 AC9 3 ASN B 95 HOH B2124 HOH B2125 SITE 1 BC1 2 LYS B 112 HIS D 113 SITE 1 BC2 3 HIS A 113 LYS C 112 HOH C2106 SITE 1 BC3 4 ARG C 29 PHE C 89 GLU C 90 HOH C2107 SITE 1 BC4 3 ARG C 29 ARG C 36 PRO C 84 SITE 1 BC5 3 ARG A 10 ILE C 170 VAL C 171 SITE 1 BC6 4 GLN C 100 GLY C 101 LYS C 124 SER C 125 SITE 1 BC7 3 ASN C 95 HOH C2077 HOH C2109 SITE 1 BC8 5 GLY A 141 GLY A 142 LEU A 143 ASP A 144 SITE 2 BC8 5 EDO C 209 SITE 1 BC9 3 ASN A 19 SO4 C 208 HOH C2110 SITE 1 CC1 3 GLY D 142 LEU D 143 ASP D 144 SITE 1 CC2 7 LYS A 157 SO4 A 205 ARG D 61 GLU D 63 SITE 2 CC2 7 LEU D 64 HOH D2119 HOH D2120 SITE 1 CC3 5 GLY D 101 LYS D 124 SER D 125 HOH D2121 SITE 2 CC3 5 HOH D2122 SITE 1 CC4 4 ARG D 29 PHE D 89 GLU D 90 HOH D2123 SITE 1 CC5 3 ARG D 29 ARG D 36 PRO D 84 SITE 1 CC6 1 ARG D 138 SITE 1 CC7 1 ASN D 19 SITE 1 CC8 1 THR D 154 SITE 1 CC9 5 PRO D 28 ARG D 29 ASP D 32 PHE D 83 SITE 2 CC9 5 PHE D 176 SITE 1 DC1 6 HIS D 49 ARG D 50 GLN D 58 BMT H 5 SITE 2 DC1 6 SAR H 7 VAL H 9 SITE 1 DC2 2 DAL G 1 MLE G 2 SITE 1 DC3 22 ARG A 50 PHE A 55 GLN A 58 ALA A 108 SITE 2 DC3 22 ASN A 109 ASP A 110 GLU A 118 PHE A 120 SITE 3 DC3 22 HIS A 128 LEU A 129 HIS A 133 ARG D 61 SITE 4 DC3 22 ARG D 78 ASP D 110 SER D 114 HOH D2043 SITE 5 DC3 22 HOH E2002 HOH E2003 HOH E2004 ABA H 6 SITE 6 DC3 22 SAR H 7 MLE H 8 SITE 1 DC4 14 ARG B 50 PHE B 55 MET B 56 GLN B 58 SITE 2 DC4 14 ALA B 108 ASN B 109 ASP B 110 PHE B 120 SITE 3 DC4 14 HIS B 128 LEU B 129 HIS B 133 ASN D 95 SITE 4 DC4 14 HOH F2001 HOH F2002 SITE 1 DC5 13 ARG C 50 PHE C 55 GLN C 58 ARG C 61 SITE 2 DC5 13 ALA C 108 ASN C 109 ASP C 110 GLU C 118 SITE 3 DC5 13 PHE C 120 HIS C 128 LEU C 129 HIS C 133 SITE 4 DC5 13 EDO G 12 SITE 1 DC6 22 ARG A 61 ARG A 78 ASP A 110 SER A 114 SITE 2 DC6 22 ASN B 95 ARG D 50 PHE D 55 MET D 56 SITE 3 DC6 22 GLN D 58 ALA D 108 ASN D 109 ASP D 110 SITE 4 DC6 22 PHE D 120 HIS D 128 HIS D 133 EDO D 211 SITE 5 DC6 22 ABA E 6 SAR E 7 MLE E 8 HOH H2002 SITE 6 DC6 22 HOH H2003 HOH H2005 CRYST1 149.631 100.805 86.184 90.00 116.28 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006683 0.000000 0.003300 0.00000 SCALE2 0.000000 0.009920 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012941 0.00000